Urine Lipoarabinomannan in HIV Uninfected, Smear Negative, Symptomatic TB Patients: Effective Sample Pretreatment for a Sensitive Immunoassay and Mass Spectrometry

Overview

Journal Sci Rep

Specialty Science

Date 2021 Feb 4

PMID 33536495

Citations 10

Authors

Anita G Amin

Prithwiraj De

Barbara Graham

Roger I Calderon

Molly F Franke

Delphi Chatterjee

Affiliations

Soon will be listed here.

Abstract

Our study sought to determine whether urine lipoarabinomannan (LAM) could be validated in a sample cohort that consisted mainly of HIV uninfected individuals that presented with tuberculosis symptoms. We evaluated two tests developed in our laboratory, and used them on clinical samples from Lima, Peru where incidence of HIV is low. ELISA analysis was performed on 160 samples (from 140 adult culture-confirmed TB cases and 20 symptomatic TB-negative child controls) using 100 μL of urine after pretreatment with Proteinase K. Two different mouse monoclonal antibodies-CS35 and CHCS9-08 were used individually for capture of urine LAM. Among cases, optical density (OD) values had a positive association with higher bacillary loads. The 20 controls had negative values (below the limit of detection). The assay correctly identified all samples (97-100% accuracy confidence interval). For an alternate validation of the ELISA results, we analyzed all 160 urine samples using an antibody independent chemoanalytical approach. Samples were called positive only when LAM surrogates-tuberculostearic acid (TBSA) and D-arabinose (D-ara)-were found to be present in similar amounts. All TB cases, including the 40 with a negative sputum smear had LAM in detectable quantities in urine. None of the controls had detectable amounts of LAM. Our study shows that urinary LAM detection is feasible in HIV uninfected, smear negative TB patients.

Citing Articles

Urine lipoarabinomannan concentrations among HIV-negative adults with pulmonary or extrapulmonary tuberculosis disease in Vietnam.

Hoa N, Fajans M, Nguyen Van H, Vu Ngoc B, Viet N, Nguyen Thi H PLOS Glob Public Health. 2024; 4(11):e0003891.

PMID: 39504319 PMC: 11540228. DOI: 10.1371/journal.pgph.0003891.

Urinary metabolic characterization of advanced tuberculous meningitis cases in a South African paediatric population.

Isaiah S, Loots D, van Reenen M, Solomons R, van Elsland S, van Furth A Front Mol Biosci. 2024; 11:1253983.

PMID: 38560518 PMC: 10978807. DOI: 10.3389/fmolb.2024.1253983.

Improving the diagnosis of active tuberculosis: a novel approach using magnetic particle-based chemiluminescence LAM assay.

Li Y, Ru Z, Wei H, Wu M, Xie G, Lou J BMC Pulm Med. 2024; 24(1):100.

PMID: 38413948 PMC: 10898140. DOI: 10.1186/s12890-024-02893-2.

Collected Thoughts on Mycobacterial Lipoarabinomannan, a Cell Envelope Lipoglycan.

Torrelles J, Chatterjee D Pathogens. 2023; 12(11).

PMID: 38003746 PMC: 10675199. DOI: 10.3390/pathogens12111281.

Proteinase K-pretreated ConA-based ELISA assay: a novel urine LAM detection strategy for TB diagnosis.

Huang H, Qu R, Wu K, Xu J, Li J, Lu S Front Microbiol. 2023; 14:1236599.

PMID: 37692407 PMC: 10485274. DOI: 10.3389/fmicb.2023.1236599.

References

Lawn S, Kerkhoff A, Nicol M, Meintjes G . Underestimation of the True Specificity of the Urine Lipoarabinomannan Point-of-Care Diagnostic Assay for HIV-Associated Tuberculosis. J Acquir Immune Defic Syndr. 2015; 69(4):e144-6. PMC: 4486367. DOI: 10.1097/QAI.0000000000000672. View

Amin A, De P, Spencer J, Brennan P, Daum J, Andre B . Detection of lipoarabinomannan in urine and serum of HIV-positive and HIV-negative TB suspects using an improved capture-enzyme linked immuno absorbent assay and gas chromatography/mass spectrometry. Tuberculosis (Edinb). 2018; 111:178-187. DOI: 10.1016/j.tube.2018.06.004. View

Gaylord H, Brennan P, Young D, Buchanan T . Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect Immun. 1987; 55(11):2860-3. PMC: 259992. DOI: 10.1128/iai.55.11.2860-2863.1987. View

Hunter S, Brennan P . Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J Biol Chem. 1990; 265(16):9272-9. View

Lawn S, Kerkhoff A, Vogt M, Wood R . Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis. 2011; 12(3):201-9. PMC: 3315025. DOI: 10.1016/S1473-3099(11)70251-1. View

Mitamura K, Shimizu H, Yamazaki M, Ichikawa M, Nagai K, Katada J . Clinical evaluation of highly sensitive silver amplification immunochromatography systems for rapid diagnosis of influenza. J Virol Methods. 2013; 194(1-2):123-8. DOI: 10.1016/j.jviromet.2013.08.018. View

Lawn S, Gupta-Wright A . Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications. Trans R Soc Trop Med Hyg. 2016; 110(3):180-5. PMC: 4755427. DOI: 10.1093/trstmh/trw008. View

Lindqvist L, Jansson P . Determination of the absolute configuration of sugar residues using gas chromatography. Method with potential for elimination of references. J Chromatogr A. 1997; 769(2):253-61. DOI: 10.1016/s0021-9673(96)00987-9. View

Lawn S, Dheda K, Kerkhoff A, Peter J, Dorman S, Boehme C . Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies. BMC Infect Dis. 2013; 13:407. PMC: 3846798. DOI: 10.1186/1471-2334-13-407. View

10.

Steingart K, Schiller I, Horne D, Pai M, Boehme C, Dendukuri N . Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014; (1):CD009593. PMC: 4470349. DOI: 10.1002/14651858.CD009593.pub3. View

11.

Paris L, Magni R, Zaidi F, Araujo R, Saini N, Harpole M . Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity. Sci Transl Med. 2017; 9(420). PMC: 6037412. DOI: 10.1126/scitranslmed.aal2807. View

12.

Armbruster D, Pry T . Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008; 29 Suppl 1:S49-52. PMC: 2556583. View

13.

De P, Shi L, Boot C, Ordway D, McNeil M, Chatterjee D . Comparative Structural Study of Terminal Ends of Lipoarabinomannan from Mice Infected Lung Tissues and Urine of a Tuberculosis Positive Patient. ACS Infect Dis. 2019; 6(2):291-301. PMC: 7212819. DOI: 10.1021/acsinfecdis.9b00355. View

14.

De P, Amin A, Graham B, Martiniano S, Caceres S, Poch K . Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway. J Cyst Fibros. 2020; 19(5):801-807. PMC: 7492412. DOI: 10.1016/j.jcf.2020.06.016. View

15.

De P, Amin A, Valli E, Perkins M, McNeil M, Chatterjee D . Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine. PLoS One. 2015; 10(12):e0144088. PMC: 4669150. DOI: 10.1371/journal.pone.0144088. View

16.

Maclean E, Broger T, Yerlikaya S, Fernandez-Carballo B, Pai M, Denkinger C . A systematic review of biomarkers to detect active tuberculosis. Nat Microbiol. 2019; 4(5):748-758. DOI: 10.1038/s41564-019-0380-2. View

17.

Shi L, Torrelles J, Chatterjee D . Lipoglycans of Mycobacterium tuberculosis: isolation, purification, and characterization. Methods Mol Biol. 2010; 465:23-45. DOI: 10.1007/978-1-59745-207-6_3. View

18.

Crawford A, Laurentius L, Mulvihill T, Granger J, Spencer J, Chatterjee D . Detection of the tuberculosis antigenic marker mannose-capped lipoarabinomannan in pretreated serum by surface-enhanced Raman scattering. Analyst. 2016; 142(1):186-196. DOI: 10.1039/c6an02110g. View

19.

Chatterjee D, Roberts A, Lowell K, Brennan P, Orme I . Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun. 1992; 60(3):1249-53. PMC: 257623. DOI: 10.1128/iai.60.3.1249-1253.1992. View

20.

Choudhary A, Patel D, Honnen W, Lai Z, Prattipati R, Zheng R . Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of , and Complexity of Antibody Specificities toward This Antigen. J Immunol. 2018; 200(9):3053-3066. PMC: 5911930. DOI: 10.4049/jimmunol.1701673. View